
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome
Jung Beom Seo, Yeon‐Kyung Choi, Hye-In Woo, et al.
Diabetes & Metabolism Journal (2019) Vol. 43, Iss. 6, pp. 830-830
Open Access | Times Cited: 37
Jung Beom Seo, Yeon‐Kyung Choi, Hye-In Woo, et al.
Diabetes & Metabolism Journal (2019) Vol. 43, Iss. 6, pp. 830-830
Open Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome
Yun Zhang, Song Zhang, Bolin Li, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 3, pp. 785-797
Open Access | Times Cited: 179
Yun Zhang, Song Zhang, Bolin Li, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 3, pp. 785-797
Open Access | Times Cited: 179
Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis
Rikke Nørregaard, Henricus A. M. Mutsaers, Jørgen Frøkiær, et al.
Physiological Reviews (2023) Vol. 103, Iss. 4, pp. 2847-2892
Open Access | Times Cited: 51
Rikke Nørregaard, Henricus A. M. Mutsaers, Jørgen Frøkiær, et al.
Physiological Reviews (2023) Vol. 103, Iss. 4, pp. 2847-2892
Open Access | Times Cited: 51
Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives
Yu Wang, Mingyue Jin, Chak Kwong Cheng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 41
Yu Wang, Mingyue Jin, Chak Kwong Cheng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 41
HIF1α-BNIP3-mediated mitophagy protects against renal fibrosis by decreasing ROS and inhibiting activation of the NLRP3 inflammasome
Jialin Li, Qisheng Lin, Xinghua Shao, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 38
Jialin Li, Qisheng Lin, Xinghua Shao, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 38
Pyroptosis in renal inflammation and fibrosis: current knowledge and clinical significance
Ya Liu, Haibo Lei, Wenyou Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 32
Ya Liu, Haibo Lei, Wenyou Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 32
Di (2-ethylhexyl) phthalate and polystyrene microplastics co-exposure caused oxidative stress to activate NF-κB/NLRP3 pathway aggravated pyroptosis and inflammation in mouse kidney
Shanshan Li, Xuedie Gu, Muyue Zhang, et al.
The Science of The Total Environment (2024) Vol. 926, pp. 171817-171817
Closed Access | Times Cited: 14
Shanshan Li, Xuedie Gu, Muyue Zhang, et al.
The Science of The Total Environment (2024) Vol. 926, pp. 171817-171817
Closed Access | Times Cited: 14
Effect and Regulation of the NLRP3 Inflammasome During Renal Fibrosis
Hong Zhang, Zhengchao Wang
Frontiers in Cell and Developmental Biology (2020) Vol. 7
Open Access | Times Cited: 69
Hong Zhang, Zhengchao Wang
Frontiers in Cell and Developmental Biology (2020) Vol. 7
Open Access | Times Cited: 69
Disulfiram inhibits inflammation and fibrosis in a rat unilateral ureteral obstruction model by inhibiting gasdermin D cleavage and pyroptosis
Yu Zhang, Ruicheng Zhang, Xiaohu Han
Inflammation Research (2021) Vol. 70, Iss. 5, pp. 543-552
Closed Access | Times Cited: 46
Yu Zhang, Ruicheng Zhang, Xiaohu Han
Inflammation Research (2021) Vol. 70, Iss. 5, pp. 543-552
Closed Access | Times Cited: 46
Research progress of endothelial‐mesenchymal transition in diabetic kidney disease
Ying Chen, Hang Zou, Hongwei Lü, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 12, pp. 3313-3322
Open Access | Times Cited: 38
Ying Chen, Hang Zou, Hongwei Lü, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 12, pp. 3313-3322
Open Access | Times Cited: 38
The NLRP3 inflammasome in fibrosis and aging: The known unknowns
Yanqing Liu, Xuezeng Xu, Wangrui Lei, et al.
Ageing Research Reviews (2022) Vol. 79, pp. 101638-101638
Closed Access | Times Cited: 33
Yanqing Liu, Xuezeng Xu, Wangrui Lei, et al.
Ageing Research Reviews (2022) Vol. 79, pp. 101638-101638
Closed Access | Times Cited: 33
Zhen-Wu-Tang Protects IgA Nephropathy in Rats by Regulating Exosomes to Inhibit NF-κB/NLRP3 Pathway
Honglian Li, Ruirui Lu, Yu Pang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 36
Honglian Li, Ruirui Lu, Yu Pang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 36
Integrated analysis reveals crosstalk between pyroptosis and immune regulation in renal fibrosis
Fengxia Bai, Longchao Han, Jifeng Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Fengxia Bai, Longchao Han, Jifeng Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Linagliptin Protects against Endotoxin-Induced Acute Kidney Injury in Rats by Decreasing Inflammatory Cytokines and Reactive Oxygen Species
Tsung-Jui Wu, Yi-Jen Hsieh, Chia‐Wen Lu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11190-11190
Open Access | Times Cited: 22
Tsung-Jui Wu, Yi-Jen Hsieh, Chia‐Wen Lu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11190-11190
Open Access | Times Cited: 22
Adenine model of chronic renal failure in rats to determine whether MCC950, an NLRP3 inflammasome inhibitor, is a renopreventive
Mahmoud S. Sabra, Fahmy K. Hemida, Essmat A. H. Allam
BMC Nephrology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Mahmoud S. Sabra, Fahmy K. Hemida, Essmat A. H. Allam
BMC Nephrology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Hederagenin inhibits high glucose‐induced fibrosis in human renal cells by suppression of NLRP3 inflammasome activation through reducing cathepsin B expression
G. Yang, Yang Wang, Hairong Jiang, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 6, pp. 1409-1420
Open Access | Times Cited: 6
G. Yang, Yang Wang, Hairong Jiang, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 6, pp. 1409-1420
Open Access | Times Cited: 6
Novel pharmacological interventions for diabetic kidney disease
Seng Kiong Tan, Jairo A Pinzón-Cortés, Mark E. Cooper
Current Opinion in Nephrology & Hypertension (2023) Vol. 33, Iss. 1, pp. 13-25
Closed Access | Times Cited: 5
Seng Kiong Tan, Jairo A Pinzón-Cortés, Mark E. Cooper
Current Opinion in Nephrology & Hypertension (2023) Vol. 33, Iss. 1, pp. 13-25
Closed Access | Times Cited: 5
Inflammasome as an Effective Platform for Fibrosis Therapy
Tingting Chen, Feng Xiao, Nan Li, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 1575-1590
Open Access | Times Cited: 12
Tingting Chen, Feng Xiao, Nan Li, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 1575-1590
Open Access | Times Cited: 12
Uncovering the Role of Anoikis-Related Genes in Modulating Immune Infiltration and Pathogenesis of Diabetic Kidney Disease
Jiaqiong Lin, Yan Lin, Xiaoyong Li, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 4975-4991
Open Access | Times Cited: 1
Jiaqiong Lin, Yan Lin, Xiaoyong Li, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 4975-4991
Open Access | Times Cited: 1
Evaluation of the Effect of an α-Adrenergic Blocker, a PPAR-γ Receptor Agonist, and a Glycemic Regulator on Chronic Kidney Disease in Diabetic Rats
Jorge Morones, Mariana Pérez, Martín Humberto Muñoz‐Ortega, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11372-11372
Open Access | Times Cited: 1
Jorge Morones, Mariana Pérez, Martín Humberto Muñoz‐Ortega, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11372-11372
Open Access | Times Cited: 1
Protective effect of exogenous hydrogen sulfide on diaphragm muscle fibrosis in streptozotocin-induced diabetic rats
Rui Yang, Qiang Jia, Yan Li, et al.
Experimental Biology and Medicine (2020) Vol. 245, Iss. 14, pp. 1280-1289
Open Access | Times Cited: 11
Rui Yang, Qiang Jia, Yan Li, et al.
Experimental Biology and Medicine (2020) Vol. 245, Iss. 14, pp. 1280-1289
Open Access | Times Cited: 11
Gemigliptin suppresses salivary dysfunction in streptozotocin-induced diabetic rats
Wan Seok Kang, Woo Kwon Jung, Su‐Bin Park, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111297-111297
Open Access | Times Cited: 9
Wan Seok Kang, Woo Kwon Jung, Su‐Bin Park, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111297-111297
Open Access | Times Cited: 9
Psidium guajava Flavonoids Prevent NLRP3 Inflammasome Activation and Alleviate the Pancreatic Fibrosis in a Chronic Pancreatitis Mouse Model
Guixian Zhang, Liming Tang, Hongbin Liu, et al.
The American Journal of Chinese Medicine (2021) Vol. 49, Iss. 08, pp. 2001-2015
Closed Access | Times Cited: 8
Guixian Zhang, Liming Tang, Hongbin Liu, et al.
The American Journal of Chinese Medicine (2021) Vol. 49, Iss. 08, pp. 2001-2015
Closed Access | Times Cited: 8
Targeting Dermal Fibroblast Subtypes in Antifibrotic Therapy: Surface Marker as a Cellular Identity or a Functional Entity?
Xin Huang, Yimin Khoong, Chengyao Han, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 7
Xin Huang, Yimin Khoong, Chengyao Han, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 7
Fluorofenidone attenuates renal fibrosis by inhibiting lysosomal cathepsin‑mediated NLRP3 inflammasome activation
Linfeng Zheng, Wenjuan Mei, Jing Zhou, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 4
Open Access
Linfeng Zheng, Wenjuan Mei, Jing Zhou, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 4
Open Access
Therapy targeted to the NLRP3 inflammasome in chronic kidney disease
Yong Ji, Hua Hu, Zhanjun Jia, et al.
Kidney Diseases (2024) Vol. 10, Iss. 5, pp. 369-383
Open Access
Yong Ji, Hua Hu, Zhanjun Jia, et al.
Kidney Diseases (2024) Vol. 10, Iss. 5, pp. 369-383
Open Access